AMSTERDAM

阿姆斯特丹

,

，

March 5, 2026

2026年3月5日

/PRNewswire/ -- Norgine, a leading European specialty pharmaceutical company, today announced a new £23 million investment in its Hengoed, Wales manufacturing site bringing the total investment at the facility to more than £50 million since 2022.

/PRNewswire/ -- 欧洲领先的专业制药公司Norgine今日宣布，将对其位于威尔士亨戈德的制造基地追加2300万英镑投资，自2022年以来，该工厂的总投资已超过5000万英镑。

Supported by the UK Government's Life Sciences Innovative Manufacturing Fund (LSIMF), this latest commitment will enable further innovation and expansion at the Hengoed site. The investment will strengthen Norgine's ability to reliably supply much-needed medicines across the UK and Europe at a time of increasing global supply chain volatility, while creating 44 new skilled jobs and reinforcing the organisation's long term manufacturing capability in the region.

在英国政府的生命科学创新制造基金 (LSIMF) 的支持下，这一最新的承诺将推动亨戈伊德工厂的进一步创新和扩展。该投资将增强Norgine在日益加剧的全球供应链波动中可靠供应英国和欧洲急需药品的能力，同时创造44个新的技术工作岗位，并强化该组织在该地区的长期制造能力。

This will be achieved through expanded production and warehousing space, the introduction of high speed, energy efficient manufacturing processes and enhanced quality control capabilities..

这将通过扩大生产及仓储空间、引入高速节能的制造工艺以及增强质量控制能力来实现。

Secretary of State for Wales, Jo Stevens said:

威尔士国务大臣乔·史蒂文斯表示：

'We have a thriving life sciences sector in Wales, and this investment from Norgine is a vote of confidence in our Welsh workforce. I am delighted that UK Government funding is supporting the business to continue to grow and create new well-paid jobs. Norgine is a brilliant example of an international business that is flourishing in Wales.'.

“威尔士拥有蓬勃发展的生命科学领域，而Norgine的投资是对我们威尔士员工队伍的信任投票。我非常高兴英国政府的资助正在支持该企业继续成长并创造新的高薪工作。Norgine是在威尔士蓬勃发展的国际企业的一个杰出例子。”

Saulo Martiniano, Chief Operating Officer at Norgine, said:

诺尔金公司的首席运营官索洛·马蒂尼奥说：

'At Norgine, we believe every scientific breakthrough should be able to reach the patients who need it, and innovative approaches to manufacturing and supply are a vital part of making that possible. By expanding and further enhancing our Hengoed facilities, we are increasing capacity, strengthening quality capabilities and investing in more energy‑efficient production.

“在Norgine，我们相信每一个科学突破都应该能够惠及需要的患者，而制造和供应方式的创新是实现这一目标的重要部分。通过扩建和进一步提升我们的亨戈伊德设施，我们正在增加产能、强化质量能力，并投资于更加节能的生产方式。”

We are proud of this investment, which will help bolster the resilience of UK and European health systems. With the enhanced capabilities at Hengoed, Wales, alongside our site in Dreux, France, and our broad network of manufacturing partners across Europe, we are well placed to navigate uncertainty and deliver medicines efficiently and consistently for years to come.'.

我们为这项投资感到自豪，这将有助于增强英国和欧洲卫生系统的韧性。随着威尔士亨戈德工厂的能力提升，加上我们在法国德勒的工厂，以及我们在欧洲广泛的制造合作伙伴网络，我们有能力应对不确定性，并在未来的岁月里高效且持续地提供药品。

This £23 million expansion forms part of a broader, long-term commitment to Hengoed. Since 2022, Norgine has invested more than £50 million at the site to enhance operations through capacity expansion and international manufacturing partnerships, such as Japan. Further investments are planned over the coming years which will result in a more resilient supply chain and more than 75 new permanent manufacturing, quality and warehouse roles in Wales..

这项2300万英镑的扩建工程是亨戈埃德更广泛、长期承诺的一部分。自2022年以来，诺尔格林已在该厂投资超过5000万英镑，通过扩大产能和与日本等国的国际制造合作来提升运营能力。未来几年还计划进一步投资，这将使供应链更具弹性，并在威尔士新增75多个永久性的生产、质量和仓储岗位。

Established manufacturing network built for resilient supply with ability to scale

建立了一个为弹性供应而打造的制造网络，具备扩展能力。

Norgine's manufacturing and supply capabilities are designed to scale with demand, supporting resilient access across Europe and beyond. The company's manufacturing infrastructure is underpinned by 60 years of expertise, with specialist engineering and systems design capabilities, supporting the production of medicines for gastrointestinal, rare and specialty conditions from both Norgine's own portfolio and selected in‑licensing partners across Europe and beyond..

Norgine的生产和供应能力旨在根据需求进行扩展，支持在欧洲及其他地区的弹性获取。公司的生产基础设施依托60年的专业经验，拥有专业的工程和系统设计能力，支持为胃肠道、罕见病和专科疾病生产药品，这些药品既来自Norgine自身的产品组合，也来自其在欧洲及其他地区精选的授权合作伙伴。

Investing in skills and giving back to the community

投资技能，回馈社区

Norgine is strengthening its long‑term commitment to the region through education and skills initiatives, including student placements with Cardiff University and apprenticeship pathways with local colleges, helping to equip the next generation of manufacturing talent.

诺尔金正在通过教育和技能计划加强其对这一地区的长期承诺，包括与卡迪夫大学合作的学生实习项目以及与当地学院合作的学徒路径，助力培养下一代制造业人才。

The Hengoed site is home to more than 600 skilled employees and currently supplies around 50 million packs of medicines and medical devices each year. Powered by 100% low‑carbon electricity, the facility reflects Norgine's commitment to sustainable manufacturing as it scales.

亨戈德工厂拥有 600 多名技术娴熟的员工，目前每年供应约 5000 万包药品和医疗器械。该工厂采用 100% 的低碳电力驱动，体现了 Norgine 在扩大规模的同时对可持续制造的承诺。

About Norgine

关于Norgine

Norgine is a mid-sized EU-based pharmaceutical company with 1,500 employees, generating approximately €650 million in annual sales. At Norgine, innovation drives our mission to deliver medicines that change lives. From common conditions like constipation to rare and severe diseases such as childhood cancer, we target unmet medical needs because we believe that every scientific breakthrough deserves to reach patients in need..

Norgine是一家总部位于欧盟的中型制药公司，拥有1500名员工，年销售额约为6.5亿欧元。在Norgine，创新推动着我们交付改变生命的药物的使命。从便秘等常见病症到儿童癌症等罕见且严重的疾病，我们致力于满足未被满足的医疗需求，因为我们相信每一个科学突破都值得惠及有需要的患者。

We use our innovative development, commercialisation and manufacturing capabilities as well as strategic partnerships to navigate complex pathways. Combined with our extensive history and deep regional expertise, this approach allows us to accelerate and expand the reach of life-changing medicines across Europe, Australia, and New Zealand..

我们利用创新的研发、商业化和制造能力，以及战略合作伙伴关系，来应对复杂的路径。结合我们悠久的历史和深厚的区域专业知识，这种方法使我们能够加速并扩大改变生命的药物在欧洲、澳大利亚和新西兰的覆盖范围。

We are guided by the trust that healthcare professionals and patients place in us and remain committed to delivering innovation that transforms lives, one patient at a time.

我们以医疗保健专业人员和患者对我们的信任为指导，始终致力于提供创新，一次改变一个患者的生活。

Logo -

标志 -

https://mma.prnewswire.com/media/2846726/5836954/Norgine_Logo.jpg

https://mma.prnewswire.com/media/2846726/5836954/Norgine_Logo.jpg

21

21

%

%

more press release views with

更多新闻发布视图与

Request a Demo

请求演示